2. Signaling Pathways
  3. Others
  4. Others

Others

 
Cat. No. Product Name Effect Purity Chemical Structure
  • HY-105628
    Prodilidine
    Prodilidine (CI-427) is an orally active, pyrrolidine-derived non-narcotic pain inhibitor. Prodilidine exerts analgesic activity against various nociceptive stimuli, and shows no antipyretic, anti-inflammatory or respiratory depressive effects. Prodilidine fails to inhibit withdrawal symptoms of addictive agents in monkeys, but exhibits excitatory effects and enhances the crossed extensor reflex at toxic doses. Prodilidine is well absorbed from the gastrointestinal tract and metabolized via hepatic microsomal N-demethylation, displaying isomer-specific activity, toxicity and metabolic characteristics. Prodilidine can be used in research related to chronic pain (e.g., cancer-, musculoskeletal/arthritis-derived), traumatic pain and arthritic pain.
    Prodilidine
  • HY-136504
    Bianthrone
    Bianthrone (Dianthrone) is a natural product that can be isolated from Rheum officinale Baill. Bianthrone is a potential toxic marker of Polygonum multiflorum Thunb.
    Bianthrone
  • HY-103641R
    (2R)-Octyl-α-hydroxyglutarate (Standard)
    (2R)-Octyl-α-hydroxyglutarate (Standard) is the analytical standard of (2R)-Octyl-α-hydroxyglutarate. This product is intended for research and analytical applications. (2R)-Octyl-α-hydroxyglutarate ((2R)-Octyl-2-HG) is a modified form of D-isomer 2-Hydroxyglutarate.
    (2R)-Octyl-α-hydroxyglutarate (Standard)
  • HY-W987949
    Z-4105
    Z-4105 is an orally active nootropic agent. Z-4105 reverses the amnesic effects of electroconvulsive shock (ECS) and methylazoxymethanol acetate (MAM), and improves learning and memory functions. Z-4105 enhances the activity of the brain cholinergic system without affecting other neurotransmitter systems. Z-4105 significantly alleviates neuropathic pain in rats. Z-4105 can be used in the research of neuropathic pain and brain dysfunction.
    Z-4105
  • HY-106329
    DMDC
    DMDC is an anti-tumor agent. DMDC induces chemotherapy-induced myelosuppression, characterized by decreases in leukocyte and neutrophil counts. DMDC can be used for the study of advanced malignancies.
    DMDC
  • HY-162164
    Neuroprotective agent 3
    Neuroprotective agent 3 (Compound 21a) is an antioxidant that exhibits neuroprotective effects. Neuroprotective agent 3 significantly increases neuronal viability and induces neuroprotection, as well as improves neurological deficit scores in an in vivo model of transient cerebral ischemia.
    Neuroprotective agent 3
  • HY-N19939
    Saponarioside D
    Saponarioside D is a triterpenoid saponin found in whole plants and roots of Saponaria officinalis L..
    Saponarioside D
  • HY-N9215
    1-Oxo-4-hydroxy-2-en-4-ethylcyclohexa-5,8-olide
    1-Oxo-4-hydroxy-2-en-4-ethylcyclohexa-5,8-olide (compound 8) is a potent anti-ulcer agent.
    1-Oxo-4-hydroxy-2-en-4-ethylcyclohexa-5,8-olide
  • HY-106769A
    (3aR,9aR)-Fluparoxan hydrochloride
    (3aR,9aR)-Fluparoxan ((3aR,9aR)-GR50360) hydrochloride is a compound that can be used to synthesize and prevent and improve neurodevelopmental disorders.
    (3aR,9aR)-Fluparoxan hydrochloride
  • HY-151496
    H-Cys-Val-2-Nal-Met-OH
    H-Cys-Val-2-Nal-Met-OH is a peptide. H-Cys-Val-2-Nal-Met-OH is a peptidomimetic derivative that can be used to label short peptide sequences.
    H-Cys-Val-2-Nal-Met-OH
  • HY-156089
    Triptoquinone H
    Triptoquinone H is a class of natural product isolated from traditional Chinese medicine Tripterygium hypoglaucu. Triptoquinone H has strong cytotoxic, immunomodulatory and anti-inflammatory activities. Triptoquinone H can be used for cancer or inflammatory diseases research.
    Triptoquinone H
  • HY-181558
    Anticancer agent 303
    Anticancer agent 303 is a selective, orally active anticancer agent belonging to the pyrazolopyridine derivatives. Anticancer agent 303 exhibits low cytotoxicity to healthy cells, with a selective window of approximately 2-fold between cancer cells and healthy cells. Anticancer agent 303 produces detectable systemic exposure in mice following intraperitoneal or oral administration. Anticancer agent 303 effectively inhibits the proliferation of prostate cancer and breast cancer cells.
    Anticancer agent 303
  • HY-N19123
    Ginsenoside Ra9
    Ginsenoside Ra9 (Compound 6) is a protopanaxadiol-type ginsenoside. Ginsenoside Ra9 can be isolated from the roots of Panax ginseng.
    Ginsenoside Ra9
  • HY-W013576R
    Methyl 2-Octynoate (Standard)
    Methyl 2-Octynoate (Standard) is the analytical standard of Methyl 2-Octynoate. This product is intended for research and analytical applications. Methyl 2-Octynoate is a hapten.
    Methyl 2-Octynoate (Standard)
  • HY-18002
    Oleanolic acid derivative 1
    		Inhibitor
    Oleanolic acid derivative 1 is an oleanolic acid derivative, which is a novel triterpenoid-steroid hybrid molecule.
    Oleanolic acid derivative 1
  • HY-165374
    AY-30068
    AY-30068 is an orally effective analgesic. AY-30068 exists in the enterohepatic circulation and has a long-lasting analgesic effect.
    AY-30068
  • HY-N19825
    Lancifodilactone B
    Lancifodilactone B is a nortriterpene found in the leaves and stems of Schisandra lancifolia.
    Lancifodilactone B
  • HY-149253
    OY-201
    OY-201 is a potential and BBB-penetrated anti-ischemic stroke agent. OY-201 shows the good safety and neuroprotective activity in both in vitro and in vivo models.
    OY-201
  • HY-151587
    Anticancer agent 89
    Anticancer agent 89 is a benzothiazole-2-thiophene S-glycoside derivative with antitumor activity, has high inhibition against the three cell line from ovarian cancer (OVCAR-4), renal cancer (A498), and melanoma (SK-MEL-5).
    Anticancer agent 89
  • HY-N1669
    2'',4''-Di-O-(E-p-Coumaroyl)afzelin
    2'',4''-Di-O-(E-p-Coumaroyl)afzelin (compound 36) is a compound isolated from Epimedium sagittatum.
    2'',4''-Di-O-(E-p-Coumaroyl)afzelin
Cat. No. Product Name / Synonyms Application Reactivity